You stated "YOU ARE ENTITLED TO YOUR OPINION BUT NOT THE FACTS" and referred to the below publicly documented information as "mumbo jumbo". Here it is...
"I can see how some confusion may occur on your part as your post 3963 listed only the inactive ingredients and you continue to represent that is all Sucanon contains, despite the active ingredients listed just above on the healthcanada website.
Now on to the specific FDA comments:
1.FDA said Sucanon is a drug per the food act
2.Although the FDA letter mentions only the "dried root radix Tricosanthes" component in the topic sentence, the FDA letter (in another section you conveniently omit) specifically states Sucanon as the trade name for the compound
3.FDA specifically references a press release announcing the presentation of the 12 week 97 subject study in in Latino prediabetics presented at the 2013 EASD annual meeting and published in their journal. The abstract of that study lists the active ingredients of Sucanon. Finally, FDA cites that very study referenced in the press release and other publicly available Sucanon study information as the basis that Sucanon has undergone "substantial clinical investigations".
The FDA letter and abstract/presentation and other Sucanon studies are publicly available and I encourage any to verify my claims. Anyone can say that's just not true. It's quite another thing to back up any claim with publicly verifiable information."
Since there is no getting around the accuracy of my post, since cited information is backed by publicly available sources, let's make this clear and easy. If anyone can disprove any factual information contained within the above quote with actual unmodified source information, then have at it. If I am shown to be wrong I will stand down. My aim here is to provide shareholders and board members accurate verifiable information about Sucanon and this company.
News 
Market Data 
Discover 
